Announcements Trials
Browse Landscape

Status

Recruiting 2Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 37Advanced Breast Cancer 5Neoplasm Metastasis 4Neoplasms 2The Neoadjuvant Therapy 1Solid Tumor, Adult 1Recurrent Uterine Corpus Carcinoma 1Hormone Receptor-positive Advanced Breast Cancer 1Hormone Receptor Positive Advanced Breast Cancer 1HR-positive, HER2-negative and PIK3CA Mutation Advanced Breast Cancer 1HR Positive/HER-2 Negative Breast Cancer 1Estrogen Receptor-positive Breast Cancer 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasm Female 1Breast Diseases 1Breast Carcinoma In Situ 1Breast Cancer Organoids 1Brain Neoplasms 1

Interventions

pyrotinib 4Letrozole 4Trastuzumab 3Docetaxel 3Anastrozole 3exemestane 2Epirubicin 2Drug Evaluation 2Doxorubicin 2Cyclophosphamide 2Capecitabine 2Aromatase Inhibitors 2palbociclib 1abemaciclib 1Vinorelbine 1Tomography, X-Ray Computed 1Tamoxifen 1Surgimend 1Sodium Chloride 1Paclitaxel 1Mammaplasty 1Liquid Biopsy 1Lead 1Lapatinib 1Goserelin 1Fulvestrant 1Drug Therapy 1Cryotherapy 1Carboplatin 1Botulinum Toxins, Type A 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Breast Diseases × Fulvestrant × Clear all
NCT06341283 2024-05-10

A Retrospective Real-world Study of Abemaciclib in HR+ Breast Cancer

The Affiliated Hospital of Qingdao University

Unknown
200 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡